CD24 and breast carcinoma: All cell lines derived from A1 tumor (A1.1, A1.8, and A1.10) exhibited a higher (1.32% to 5%) fraction of CD44+/CD24- cells, which correlate with the phenotype of human breast cancer stem cells (Figure 1d).